antibody-drug binding technology
Scope
Date
~
-
Bio & Pharma
Celltrion unveils cancer medicine to expand new drug pipelines
South Korea’s leading biosimilar drug developer Celltrion Inc. on Sunday unveiled an anticancer medicine to expand new pipelines and accelerat...
Apr 28, 2025 (Gmt+09:00)
-
Korean chipmakers
SK Hynix makes strides in CXL technology, escalating rivalry
SK Hynix Inc., the leading global high-bandwidth memory (HBM) chip provider, has moved faster than its rivals in the commercialization of the next-g...
Apr 23, 2025 (Gmt+09:00)
-
Bio & Pharma
Celltrion expands footprint in Latin America with flagship oncology drugs
South Korea’s biopharmaceutical giant Celltrion Inc. has solidified its presence in South America after winning supply contracts for its flags...
Apr 17, 2025 (Gmt+09:00)
-
Bio & Pharma
Celltrion wins Australian approval for eye, bone disease biosimilars
Celltrion Inc. said Wednesday it has received regulatory approval from Australia’s Therapeutic Goods Administration (TGA) for three biosimilar...
Apr 10, 2025 (Gmt+09:00)
-
Shipping & Shipbuilding
Samsung Heavy makes breakthrough in FLNG liquefaction technology
Samsung Heavy Industries Co., a major Korean shipbuilder, has made a breakthrough in its liquefaction technology for floating liquefied natural gas ...
Mar 26, 2025 (Gmt+09:00)
-
Bio & Pharma
Celltrion to sell autoimmune drug Stelara biosimilar at Costco in US
South Korea’s leading biosimilar drug developer Celltrion Inc. said on Monday it is set to sell Steqeyma, a biosimilar to autoimmune disease t...
Mar 25, 2025 (Gmt+09:00)
-
Bio & Pharma
SillaJen: First to use lab-grown human tissue to find best cancer drug dose
South Korean biotechnology firm SillaJen Inc. is pioneering a new approach to determine the best dose for a cancer drug combination in clinical tria...
Mar 18, 2025 (Gmt+09:00)
-
Hydrogen economy
Samsung E&A buys Norwegian Nel stake for hydrogen business push
South Korea’s Samsung E&A Co. has purchased a stake in Norway’s hydrogen technology company Nel ASA at 47.6 billion won ($32.8 milli...
Mar 12, 2025 (Gmt+09:00)
-
Bio & Pharma
Samsung, Celltrion lead biosimilar market in Europe, US
Samsung Bioepis Co. and Celltrion Inc. are outpacing long-established global drug manufacturers such as Amgen Inc. and Sandoz in the antibody biosim...
Mar 10, 2025 (Gmt+09:00)
-
Shipping & Shipbuilding
HD Hyundai, Palantir chiefs discuss AI shipyard, defense technology
Chung Kisun, executive vice chairman of the world’s largest shipbuilder HD Hyundai Co., has met with Alex Karp, CEO of Palantir Technologies I...
Mar 09, 2025 (Gmt+09:00)
-
Bio & Pharma
Chong Kun Dang to build new plant for foray into biologics market
Chong Kun Dang Pharmaceutical Corp. is discussing building a research center and a plant in Siheung, about 30 kilometers southwest of Seoul, with th...
Feb 27, 2025 (Gmt+09:00)
-
Machinery
Hyundai Rotem inks $1.5 bn Morocco train supply deal
South Korea’s Hyundai Rotem Co. said on Wednesday it has won a 2.2 trillion won ($1.5 billion) train order from Morocco, the biggest single de...
Feb 26, 2025 (Gmt+09:00)
-
Bio & Pharma
Celltrion wins EU approval for autoimmune disease treatment Avtozma
Celltrion Inc.’s Avtozma, a biosimilar to Roche’s autoimmune disease treatment Actemra, has won approval from the European Commission, f...
Feb 25, 2025 (Gmt+09:00)
-
Aerospace & Defense
S.Korea’s defense order backlog reaches record $73.1 billion at end-2024
South Korea’s seven major defense companies saw their combined order backlog reach a record 105.6 trillion won ($73.1 billion) at the end of 2...
Feb 17, 2025 (Gmt+09:00)
-
Private equity
EQT targets healthcare, technology, business service providers in Korea
EQT, the largest private equity firm in Europe, is setting its sights on healthcare, technology companies and business service providers in South Ko...
Feb 14, 2025 (Gmt+09:00)
-
Bio & Pharma
Lotte Biologics eyes first ADC CDMO order in 2025
SAN FRANCISCO -- Lotte Biologics Co., the drug consignment development and production unit of South Korean conglomerate Lotte Group, will seek to wi...
Jan 17, 2025 (Gmt+09:00)
-
IPOs
Celltrion seeks large-scale M&A in Q4, eyes 2027 Nasdaq debut
SAN FRANCISCO – South Korea’s leading biosimilar drug developer Celltrion Inc. seeks to acquire a domestic health food maker as early as...
Jan 16, 2025 (Gmt+09:00)
-
Bio & Pharma
SK Biopharmaceuticals, Eurofarma to set up AI epilepsy platform JV in US
South Korea’s SK Biopharmaceuticals Co. has signed a deal with Brazil’s Eurofarma Laboratórios S.A. to establish a joint venture ...
Jan 15, 2025 (Gmt+09:00)
-
Automobiles
Hyundai Mobis to boost US production to cope with Trump
LAS VEGAS -- Hyundai Mobis Co., the world’s fifth-largest auto parts maker, plans to beef up its US production to cope with President-elect Do...
Jan 12, 2025 (Gmt+09:00)
-
Korean Innovators at CES 2025
LG Electronics bets big on humanoid robots: CEO Cho
LAS VEGAS – South Korea’s top home appliance maker LG Electronics Inc. has thrown down the gauntlet to frontrunners in the AI robot race...
Jan 09, 2025 (Gmt+09:00)
-
Automobiles
Hyundai Motor vows record investment of $16.7 bn in South Korea
Hyundai Motor Group will invest 24.3 trillion won ($16.7 billion) this year in South Korea, the largest-ever annual investment in its home country, ...
Jan 09, 2025 (Gmt+09:00)
-
Bio & Pharma
Yuhan’s lung cancer drug gets OK in Europe
Leclaza (ingredient: lazertinib), a new lung cancer treatment developed by South Korea’s Yuhan Corp. secured approval from the European Commis...
Dec 31, 2024 (Gmt+09:00)
-
Automobiles
Hyundai AutoEver establishes JV in Indonesia
South Korea's Hyundai AutoEver Corp. said on Monday it built the joint venture PT Terra Link technology in Indonesia with India's MapmyIndia. T...
Dec 16, 2024 (Gmt+09:00)
-
Artificial intelligence
SK Telecom invests $3 mn in AI-powered video analysis startup Twelve Labs
South Korea’s top mobile carrier SK Telecom Co. said on Friday it will invest $3 million in Twelve Labs Inc., a Korean AI-powered video analys...
Dec 13, 2024 (Gmt+09:00)
-
Bio & Pharma
Boryung, Lotus Pharma signs CDMO deal on anticancer injection
South Korea's Boryung Corp. said on Thursday it signed a contract with Lotus Pharmaceutical, a Taiwanese oncology firm, for contract development and...
Dec 12, 2024 (Gmt+09:00)
-
Steel
POSCO Future M develops technology to make electrode rods
POSCO Future M Co., a battery material and steel manufacturing equipment supplier, said on Thursday it has developed electrode rod manufacturing tec...
Dec 12, 2024 (Gmt+09:00)
-
Electronics
Korean displays regain top spot with premium information tech OLEDs
South Korean display makers regained ground in the global organic light-emitting diode (OLED) panel market in the second quarter, elbowing out the p...
Dec 05, 2024 (Gmt+09:00)
-
Bio & Pharma
SK Biopharm submits NDA of epilepsy drug to China
South Korea's SK Biopharmaceuticals Co. said on Tuesday it submitted the new drug application (NDA) for its flagship epilepsy drug Cenobamate to Chi...
Dec 05, 2024 (Gmt+09:00)
-
Cloud computing
CJ OliveNetworks to expand cloud management biz
South Korea's CJ OliveNetworks said on Wednesday it will expand its managed service provider (MSP) in the cloud industry, utilizing Naver Cloud and ...
Dec 04, 2024 (Gmt+09:00)
-
Korean chipmakers
SK Hynix to produce HBM4 on 3 nm foundry process in 2025
SK Hynix Inc. will adopt the 3-nanometer process, the most advanced foundry technology available, to produce customized HBM4 chips in the second hal...
Dec 03, 2024 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand